Newsmeme!
Discover News you didn't know existed
Biotechnology
News
Related Video News
No related video news stories found.
Related Videos
No related videos found.
Indiana drug research, manufacturing rose in '09
Published February 10, 2010, 6:39 am, The Indianapolis Star
Indiana's contract drug research and manufacturing companies continued to expand in 2009, despite the economic downturn, uncertainly related to healthcare reform, and other market developments, according to a new report today.
Research and Markets: Company Financials: Baxter International Inc.
Published February 10, 2010, 6:37 am, Business Wire via Yahoo! Finance
DUBLIN----Research and Markets has announced the addition of the "Company Financials: Baxter International Inc." company profile to their offering.
Expanded London Genetics Web Site Emphasises Importance of Pharmacogenetics in Drug Development
Published February 10, 2010, 6:24 am, PR Newswire via Yahoo! Finance
London Genetics Limited, an expert in the use of pharmacogenetics in clinical drug discovery and development, is pleased to announce the launch of its expanded web site. The site, which was designed by Opus Design Consultants, highlights how pharmacogenetics can help to target drugs to those patients most likely to benefit, and to increase safety and cost-effectiveness.
Oramed's Chief Scientific Officer, Miriam Kidron, Ph.D., Chosen to Lecture at the Third International Conference on ...
Published February 10, 2010, 6:20 am, PR Newswire via Yahoo! Finance
Oramed Pharmaceuticals, Inc. , a developer of alternative drug delivery systems, announced today that its Chief Scientific Officer, Miriam Kidron, Ph.D., was chosen to lecture at the Third International Conference on Advanced Technologies and Treatments for Diabetes to take place in Basel, Switzerland on February 11, 2010.
Psoriasis drug Enbrel to account for less than one-fifth of sales in 2018 overall market
Published February 10, 2010, 6:10 am, News-Medical-Net
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, owing to increasing competition from other biologic agents, Amgen/Pfizer/Takeda's Enbrel (etanercept)—the leading therapy in the psoriasis drug market in 2008—will account for less than one-fifth of sales in the overall market in 2018. In 2008, Enbrel garnered half of ...
Life Sciences Venture Capital Funding Overcomes Record Lows, Outpaces Other Sectors, According to PricewaterhouseCoopers
Published February 10, 2010, 6:00 am, PR Newswire via Yahoo! Finance
Companies in the Life Sciences sector, which includes the biotechnology and medical device industries, captured the largest share of overall venture capital during 2009, reflecting the relative strength of the sector during the economic downturn, according to PricewaterhouseCoopers LLP .
Capstone Therapeutics to Host Quarterly Update Conference Call
Published February 10, 2010, 6:00 am, GlobeNewswire via Yahoo! Finance
TEMPE, Ariz. -- Capstone Therapeutics , trade name of OrthoLogic Corp. will host a conference call and webcast on Wednesday, February 17, 2010 at 4:30pm EST / 3:30pm CST / 2:30pm MST / 1:30pm PST. The call may be accessed at 888-857-6932 , 719-457-2637 ; accompanying slides can be viewed by logging onto the Investors section of the Company's website, www.capstonethx.com[[[SHIFTIN ...
DSP Clinical Research Cites 5 Mistakes Sponsors Make When Choosing a CRO
Published February 10, 2010, 6:00 am, Business Wire via Yahoo! Finance
PARSIPPANY, N.J.----DSP Clinical Research has identified five errors pharmaceutical, biotech and medical device companies make when selecting a CRO to conduct a clinical study. DSP is a full service CRO that uses innovative approaches to successfully manage Phase I-IV clinical studies.
Lung Rx and ImmuneWorks Announce Collaboration in Idiopathic Pulmonary Fibrosis and Primary Graft Dysfunction
Published February 10, 2010, 6:00 am, PR Newswire via Yahoo! Finance
Lung Rx, LLC, a wholly-owned subsidiary of United Therapeutics Corporation , announced today that it has entered into a Development Agreement with ImmuneWorks, Inc. to pursue development of ImmuneWorks' lead compound, IW001, a purified bovine Type V Collagen oral solution for the treatment of Idiopathic Pulmonary Fibrosis and Primary Graft Dysfunction in patients receiving lung transplant. Â The ...
Biomagnetics to Accelerate Availability of the World's First Integrated Optical Biosensor for Malaria, Cholera, TB and ...
Published February 10, 2010, 6:00 am, Business Wire via Yahoo! Finance
SAN FRANCISCO----Biomagnetics Diagnostics Corp. , a developer of revolutionary diagnostic systems and technology for malaria, HIV/AIDS, hepatitis, tuberculosis and detection, announced today the implementation of a program to accelerate the availability of the world's first Integrated Optical BioSensor platform.
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |